Spinelogik Inc.

Spinelogik Inc. is a privately held entity primarily engaged in patent assertion, focusing on spinal implant technology. Its headquarters and year of founding could not be definitively verified through public sources. The company does not appear to manufacture or distribute medical devices itself, but rather monetizes intellectual property related to the field.

Spinelogik Inc.'s operations are centered on its patent portfolio, which includes U.S. Patent No. 8,460,385 and U.S. Patent No. 9,730,805. These patents cover spinal implant technology, specifically directed at cervical standalone systems. As a non-practicing entity (NPE), Spinelogik Inc. leverages these patents to assert infringement claims against companies operating in the medical device sector.

The company's patent litigation posture is that of a patent assertion entity, evidenced by its record of one tracked case as a plaintiff and zero as a defendant. This aligns with its strategy of intellectual property monetization. All tracked litigation has occurred in the U.S. District Court for the Eastern District of Texas, a venue frequently chosen by plaintiffs in patent infringement suits.

The most notable case involving Spinelogik Inc. is Spinelogik, Inc. v. Genesys Orthopedics Systems, LLC (Case No. 2:23-cv-00297), filed in the Eastern District of Texas. This suit targeted multiple defendants, including Genesys Orthopedics Systems, LLC, Zimmer Biomet Holdings, Inc., and Choice Spine, LLC, over alleged infringement of its spinal implant patents. The case was voluntarily dismissed by Spinelogik Inc. without a ruling on the merits in February 2026, with the lead case dismissed "without prejudice," preserving the possibility of future assertion. Furthermore, Globus Medical, Inc. initiated an inter partes review (IPR) against Spinelogik's U.S. Patent 8,460,385, which the Patent Trial and Appeal Board (PTAB) subsequently instituted.